A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy and Safety of Ethyl-Ester Omega-3 Fatty Acid in Taiwanese Hypertriglyceridemic Patients-Reference-Cited by-同舟云学术

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy and Safety of Ethyl-Ester Omega-3 Fatty Acid in Taiwanese Hypertriglyceridemic Patients

Published:2017 Issue:3 Volume:24 Page:275-289
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Su Ta-Chen¹²,Hwang Juey-Jen¹,Huang Kuo-Chin³,Chiang Fu-Tien¹,Chien Kuo-Liong¹⁴,Wang Kuo-Yang⁵,Charng Min-Ji⁶,Tsai Wei-Chuan⁷,Lin Lian-Yu¹,Vige Runar⁸,Olivar José Emilio Ruiz⁹,Tseng Chuen-Den¹¹⁰

Affiliation:

1. Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital

2. Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health

3. Department of Family Medicine, National Taiwan University Hospital

4. Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University

5. Cardiovascular Center and Department of Anesthesiology, Taichung Veterans General Hospital

6. Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital

7. Division of Cardiology, Internal Medicine, National Cheng Kung University Hospital

8. Pronova Biopharma Norge AS

9. Ferrer Group

10. Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/24/3/24_34231/_pdf

Reference32 articles.

1. 1) Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al.: Triglycerides and cardiovascular dis ease: a scientific statement from the American Heart Association. Circulation, 2011; 123: 2292-2333

2. 2) Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Boren J, Catapano AL, et al.: Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J, 2011; 32: 1345-1361

3. 3) Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM: Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Expert Opin Pharmacother, 2008; 9: 1237-1248

4. 4) Kris-Etherton PM, Harris WS, Appel LJ: Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol, 2003; 23: 151-152

5. 5) Rupp H: Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia. Adv Ther, 2009; 26: 675-690

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Advances in Nutrition;2023-11

2. Association Between Omega‐3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose–Response Meta‐Analysis of Randomized Controlled Trials;Journal of the American Heart Association;2023-06-06

3. Dietary interventions for perinatal depression and anxiety: a systematic review and meta-analysis of randomized controlled trials;The American Journal of Clinical Nutrition;2023-06

4. Nutritional Treatment of Hypertriglyceridemia in Childhood: From Healthy-Heart Counselling to Life-Saving Diet;Nutrients;2023-02-22

5. The effect of omega-3 fatty acids and its combination with statins on lipid profile in patients with hypertriglyceridemia: A systematic review and meta-analysis of randomized controlled trials;Frontiers in Nutrition;2022-10-13